Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Bacterial Infections and Mycoses (1)
- Biochemical Phenomena, Metabolism, and Nutrition (1)
- Biochemistry, Biophysics, and Structural Biology (1)
- Bioinformatics (1)
- Biotechnology (1)
-
- Dietetics and Clinical Nutrition (1)
- Digestive, Oral, and Skin Physiology (1)
- Food Microbiology (1)
- Food Science (1)
- Genetics and Genomics (1)
- Genomics (1)
- Human and Clinical Nutrition (1)
- Immunology of Infectious Disease (1)
- Immunotherapy (1)
- Medical Microbiology (1)
- Medical Pathology (1)
- Microbial Physiology (1)
- Nutrition (1)
- Nutritional Epidemiology (1)
- Nutritional and Metabolic Diseases (1)
- Parasitic Diseases (1)
- Parasitology (1)
Articles 1 - 2 of 2
Full-Text Articles in Microbiology
Campylobacter Ureolyticus: An Emerging Gastrointestinal Pathogen?, Susan Bullman, Daniel Corcoran, James O'Leary, Brigid Lucey, Deirdre Byrne, Roy D. Sleator
Campylobacter Ureolyticus: An Emerging Gastrointestinal Pathogen?, Susan Bullman, Daniel Corcoran, James O'Leary, Brigid Lucey, Deirdre Byrne, Roy D. Sleator
Department of Biological Sciences Publications
A total of 7194 faecal samples collected over a 1-year period from patients presenting with diarrhoea were screened for Campylobacter spp. using EntericBios, a multiplex-PCR system. Of 349 Campylobacter-positive samples, 23.8% were shown to be Campylobacter ureolyticus, using a combination of 16S rRNA gene analysis and highly specific primers targeting the HSP60 gene of this organism. This is, to the best of our knowledge, the first report of C. ureolyticus in the faeces of patients presenting with gastroenteritis and may suggest a role for this organism as an emerging enteric pathogen.
Probiotic Therapy - Recruiting Old Friends To Fight New Foes, Roy D. Sleator
Probiotic Therapy - Recruiting Old Friends To Fight New Foes, Roy D. Sleator
Department of Biological Sciences Publications
Against a backdrop of increasing antibiotic resistance, and the emergence of new and evolving pathogens, clinicians are increasingly forced to consider alternative therapies - probiotics are one such alternative.